Beijing Balance Medical Technology Co Ltd
SSE:688198
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
|
Beijing Balance Medical Technology Co Ltd
SSE:688198
|
12.9B CNY |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.4B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.5B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.8B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.1B USD |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.3B USD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.1B AUD |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
Beijing Balance Medical Technology Co Ltd
Glance View
Beijing Balance Medical Technology Co Ltd, a pivotal player in the Chinese healthcare landscape, has carved out a niche by embracing a fusion of innovation and practicality within the medical technology sector. Founded to seamlessly integrate cutting-edge technology with healthcare delivery, the company has successfully positioned itself within the burgeoning market for medical devices and equipment. Balance Medical’s core operations revolve around the design, development, and production of high-precision medical instruments that cater to a wide array of medical needs, ranging from diagnostics to therapeutic equipment. They have often set themselves apart through their commitment to research and development, driving the creation of state-of-the-art solutions that streamline medical procedures and enhance patient care. The company's revenue model hinges on a robust portfolio of products, which includes advanced imaging systems, surgical equipment, and monitoring devices that are indispensable in modern medical facilities. Through strategic partnerships and collaborations with healthcare institutions and medical professionals, Beijing Balance Medical Technology Co Ltd ensures a continuous feedback loop, allowing them to refine and expand their offerings. Moreover, their adeptness at navigating the regulatory landscape in China provides a steady flow of approvals and certifications, facilitating swift market entry and adoption. By focusing on both domestic demand and exploring international markets, the company generates returns not only through direct sales but also by licensing their technology and forming joint ventures, anchoring its position as a forward-thinking entity in the medical technology arena.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Beijing Balance Medical Technology Co Ltd is 86.8%, which is below its 3-year median of 88.3%.
Over the last 3 years, Beijing Balance Medical Technology Co Ltd’s Gross Margin has decreased from 88.8% to 86.8%. During this period, it reached a low of 86.7% on Mar 31, 2025 and a high of 89.8% on Dec 31, 2023.